Boris Peaker analyst TD COWEN

Currently out of the existing stock ratings of Boris Peaker, 21 are a HOLD (39.62%), 32 are a BUY (60.38%).

Boris Peaker

Work Performance Price Targets & Ratings Chart

Analyst Boris Peaker works at TD COWEN with a stock forecast success ratio of 59.84% fulfilled within 148.88 days on average. Previously, Boris Peaker worked at COWEN.

Boris Peaker’s has documented 99 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HRTX, Heron Therapeuti at 15-Nov-2023.

Wall Street Analyst Boris Peaker

Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 4/17/2023. The price target of $8 was fulfilled within 23 days with a profit of $3.6 (81.82%) receiving and performance score of 35.57.

Average potential price target upside

CLDX Celldex Therapeutics EBS Emergent Biosolutions HRTX Heron Therapeuti SGEN Seagen IRWD Ironwood Pharmaceuticals JNCE Jounce Therapeutics AADI Aadi Bioscience CTMX CytomX Therapeutics NKTR Nektar Therapeutics MRK Merck mpany CTIC CTi Biopharma Corp PCRX Pacira Pharmaceuticals ADCT ADC Therapeutics SA PNT POINT Biopharma Global

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$48.21 (115.36%)

72

1 months 2 days ago

0/4 (0%)

$38.96 (76.33%)

Hold

27

$-14.79 (-35.39%)

21

4 months 19 days ago

1/2 (50%)

$0.06 (0.22%)

4

Buy

80

$38.21 (91.43%)

73

4 months 23 days ago

6/15 (40%)

$50.65 (172.57%)

256

Buy

52

$10.21 (24.43%)

54

4 months 26 days ago

4/11 (36.36%)

$26.02 (100.15%)

62

Buy

68

$26.21 (62.72%)

70

7 months 18 days ago

0/3 (0%)

$37.77 (124.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Boris Peaker is most bullish on?

Potential upside of $-0.24 has been obtained for HRTX (HERON THERAPEUTI)

What Year was the first public recommendation made by Boris Peaker?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?